Thiazolidinedione derivatives and pharmaceutical compositions containing same
A technology of thiazolidinedione and compounds, applied in the field of thiazolidinedione derivatives and pharmaceutical compositions containing them, capable of solving problems such as limited therapeutic application and weight gain
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0177] (E)-2-(4-(4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy)phenyl)-3-(3-methoxy-5- (methoxy-d 3 ) Preparation of phenyl) methyl acrylate
[0178]
[0179] The first step: 3-hydroxy-5-(methoxy-d 3 ) preparation of benzaldehyde
[0180] 3,5-Dihydroxybenzaldehyde (5.6 g, 40.54 mmol), potassium carbonate (7.5 g, 54.27 mmol) and N,N-dimethylformamide (100 mL) were sequentially added to a 500 mL round bottom flask. Under ice bath (0-5°C), add p-toluenesulfonic acid-d dropwise over 30 minutes 3 - A solution of the methyl ester (6.85 g, 36.20 mmol) in N,N-dimethylformamide (50 mL). The reaction solution was then reacted at 0-5°C for 1 hour, and then raised to room temperature for 18 hours. The resulting mixture was quenched with water (200 mL), then adjusted to pH 2 with hydrochloric acid and extracted with ethyl acetate (100 mL×4). The combined organic phases were washed with saturated brine, dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentr...
Embodiment 2
[0200] (E)-3-(3,5-bis(methoxy-d 3 )Phenyl)-2-(4-(4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy)phenyl)methyl acrylate
[0201]
[0202] The first step: 3,5-bis(methoxy-d 3 ) preparation of benzaldehyde
[0203] In a 100mL round bottom flask, add 3,5-dihydroxybenzaldehyde (4g, 28.96mmol), p-toluenesulfonic acid-d 3- Methyl ester (12g, 63.70mmol), potassium carbonate (12g, 86.88mmol) and N,N-dimethylformamide (50mL). The reaction solution was heated to 65°C for 32 hours, cooled to room temperature, quenched with water (300 mL), and extracted with ethyl acetate (100 mL×2). The combined organic phases were washed with saturated brine (100 mL×2), dried over anhydrous magnesium sulfate, and filtered. The filtrate was concentrated under reduced pressure to obtain the target compound (crude product 4.67 g), which was directly used in the next reaction without purification.
[0204] 1 H NMR (400MHz, DMSO-d 6 ) δ9.93 (s, 1H), 7.07 (d, J = 2.4Hz, 2H), 6.83 (t, J = 2.4Hz, 1H).
...
Embodiment 3
[0221] (E)-3-(3,5-bis(methoxy-d 3 ) phenyl) -2-(4-(4-((2,4-dioxothiazolidine-5-yl) methyl) phenoxy) phenyl) acrylic acid
[0222]
[0223] The first step: (E)-3-(3,5-bis(methoxy-d 3 ) phenyl) -2-(4-(4-((2,4-dioxothiazolidine-5-yl) methyl) phenoxy) phenyl) acrylic acid
[0224] Add (E)-3-(3,5-bis(methoxy-d 3 )phenyl)-2-(4-(4-((2,4-dioxothiazolidin-5-yl)methyl)phenoxy)phenyl)methyl acrylate (0.88g, 1.67mmol), Lithium hydroxide monohydrate (200 mg, 4.76 mmol), tetrahydrofuran (4 mL) and water (3 mL). The reaction solution was reacted at room temperature for 24 hours, then quenched with water (10 mL), and then extracted with ethyl acetate (10 mL×3). The aqueous phase was adjusted to pH 1 with hydrochloric acid and then filtered. The filter cake was washed with water and dried to obtain a crude product. The obtained crude product was purified by silica gel column chromatography to obtain the target compound (0.66 g, yield 77.1%).
[0225] LC-MS: m / z 512(M+H) + . 1 H NMR ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com